CLB Stock Recent News

EQNR secures a 9.8% stake in Orsted, becoming the latter's second-largest shareholder and advancing its commitment to offshore wind and renewable energy growth.

CLB is a compelling investment in the oilfield services sector, featuring strong fundamentals, innovative technologies and a disciplined financial strategy poised for growth.

Considering OPEC's optimistic oil demand growth forecast, we recommend buying stocks like CLB, FTI and TUWOY.

Here is how Core Laboratories (CLB) and Talen Energy Corporation (TLN) have performed compared to their sector so far this year.

The heavy selling pressure might have exhausted for Core Laboratories (CLB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here is how Core Laboratories (CLB) and Ranger Energy (RNGR) have performed compared to their sector so far this year.

Core Laboratories (CLB) expects Reservoir Description revenues of $86.5-$89.5 million and Production Enhancement revenues of $44.5-$47.5 million for the third quarter of 2024.

Core Laboratories (CLB) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.21 per share a year ago.

Core Laboratories (CLB) is expected to report higher revenues from the year-ago period's level. It is also likely to have incurred higher operating expenses.